Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Traws Pharma, Inc.ONTX · Entity 8032 | Director · PRESIDENT, CHIEF EXECUTIVE OFF | March 13, 2024 | March 15, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Traws Pharma, Inc.
Report date March 13, 2024 · Filed March 15, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 74,792 |
Ending reported balance
After 2024-03-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-03-13 · Exercise / conversion · Acquired 23,111 · Balance 83,519 F1: Restricted stock units convert into common stock on a one-for-one basis. Row 2 · 2024-03-14 · Tax withholding · Disposed 8,727 · Balance 74,792 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 46,222 |
Reported balance
After 2024-03-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-03-13 · Exercise / conversion · Disposed 23,111 · Balance 46,222 F1: Restricted stock units convert into common stock on a one-for-one basis. F2: On March 13, 2023 the reporting person was granted 69,333 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: On March 13, 2023 the reporting person was granted 69,333 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2024 Filed Mar 15, 2024 21:36 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | Tax withholdingCommon Stock | 8,727 | $0.90 | $7,854.30 |
DisclosureSEC source: 0001415889-24-008141 · form4-03152024_090321.xml · nonDerivative · entry 2 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,792 Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 21:36 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | Exercise / conversionRestricted Stock Units · Derivative | 23,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-008141 · form4-03152024_090321.xml · derivative · entry 3 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,222 Underlying: Common Stock · 23,111 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On March 13, 2023 the reporting person was granted 69,333 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary. F2 · derivative.expiration_date: On March 13, 2023 the reporting person was granted 69,333 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 21:36 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | Exercise / conversionCommon Stock | 23,111 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-008141 · form4-03152024_090321.xml · nonDerivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 22:36 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | Exercise / conversionRestricted Stock Units · Derivative | 21,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-003204 · form4-02092024_100217.xml · derivative · entry 3 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,320 Underlying: Common Stock · 21,320 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On February 7, 2022 the reporting person was granted 63,960 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary. F2 · derivative.expiration_date: On February 7, 2022 the reporting person was granted 63,960 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 22:36 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | Tax withholdingCommon Stock | 9,212 | $0.67 | $6,172.04 |
DisclosureSEC source: 0001415889-24-003204 · form4-02092024_100217.xml · nonDerivative · entry 2 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,408 Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 22:36 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | Exercise / conversionCommon Stock | 21,320 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-003204 · form4-02092024_100217.xml · nonDerivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,620 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| August 03, 2023 Filed Aug 4, 2023 20:42 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | Tax withholdingCommon Stock | 4,744 | $1.01 | $4,791.44 |
DisclosureSEC source: 0001415889-23-011866 · form4-08042023_080842.xml · nonDerivative · entry 2 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,300 Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 20:42 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | Exercise / conversionRestricted Stock Units · Derivative | 12,567 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-011866 · form4-08042023_080842.xml · derivative · entry 3 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,567 Underlying: Common Stock · 12,567 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On August 2, 2021 the reporting person was granted 37,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. F2 · derivative.expiration_date: On August 2, 2021 the reporting person was granted 37,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 20:42 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | Exercise / conversionCommon Stock | 12,567 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-011866 · form4-08042023_080842.xml · nonDerivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 22:48 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantRestricted Stock Units · Derivative | 69,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004866 · form4-03142023_100340.xml · derivative · entry 2 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,333 Underlying: Common Stock · 69,333 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit is convertible into one share of common stock. F3 · derivative.exercise_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary F3 · derivative.expiration_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 22:48 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 207,000 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001415889-23-004866 · form4-03142023_100340.xml · derivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,000 Underlying: Common Stock · 207,000 shares Expires 2033-03-13 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| February 07, 2023 Filed Feb 8, 2023 23:00 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | Exercise / conversionRestricted Stock Units · Derivative | 21,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-002171 · form4-02082023_110217.xml · derivative · entry 3 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,640 Underlying: Common Stock · 21,320 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On February 7, 2022 the reporting person was granted 63,960 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary. F2 · derivative.expiration_date: On February 7, 2022 the reporting person was granted 63,960 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary. Read SEC document |
| February 07, 2023 Filed Feb 8, 2023 23:00 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | Tax withholdingCommon Stock | 6,977 | $1.36 | $9,488.72 |
DisclosureSEC source: 0001415889-23-002171 · form4-02082023_110217.xml · nonDerivative · entry 2 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,477 Read SEC document |
| February 07, 2023 Filed Feb 8, 2023 23:00 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | Exercise / conversionCommon Stock | 21,320 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-002171 · form4-02082023_110217.xml · nonDerivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| August 03, 2022 Filed Aug 4, 2022 20:30 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | Tax withholdingCommon Stock | 4,562 | $1.32 | $6,021.84 |
DisclosureSEC source: 0001415889-22-008258 · form4-08042022_010852.xml · nonDerivative · entry 2 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,134 Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 20:30 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | Exercise / conversionRestricted Stock Units · Derivative | 12,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-008258 · form4-08042022_010852.xml · derivative · entry 3 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,134 Underlying: Common Stock · 12,566 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On August 2, 2021 the reporting person was granted 37,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. F2 · derivative.expiration_date: On August 2, 2021 the reporting person was granted 37,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 20:30 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | Exercise / conversionCommon Stock | 12,566 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-008258 · form4-08042022_010852.xml · nonDerivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:41 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantRestricted Stock Units · Derivative | 63,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000963 · edgar.xml · derivative · entry 2 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,960 Underlying: Common stock · 63,960 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit is convertible into one share of common stock. F2 · derivative.exercise_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. F2 · derivative.expiration_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:41 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 191,880 | $0.00 Strike: $1.82 | $0.00 |
DisclosureSEC source: 0001179110-22-000963 · edgar.xml · derivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,880 Underlying: Common stock · 191,880 shares Expires 2032-02-07 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| September 28, 2021 Filed Sep 28, 2021 16:34 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseCommon Stock | 2,381 | $4.20 | $10,000.20 |
DisclosureSEC source: 0001179110-21-008956 · edgar.xml · nonDerivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,130 Read SEC document |
| August 02, 2021 Filed Aug 5, 2021 00:04 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantRestricted Stock Unit · Derivative | 37,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-007925 · edgar.xml · derivative · entry 2 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,700 Underlying: Common stock · 37,700 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit is convertible into one share of common stock. F2 · derivative.exercise_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. F2 · derivative.expiration_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Read SEC document |
| August 02, 2021 Filed Aug 5, 2021 00:04 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 113,000 | $0.00 Strike: $5.19 | $0.00 |
DisclosureSEC source: 0001179110-21-007925 · edgar.xml · derivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,000 Underlying: Common stock · 113,000 shares Expires 2031-08-02 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:25 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Appreciation Right · Derivative | 706,000 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0001179110-21-002006 · edgar.xml · derivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 706,000 Underlying: Common Stock · 706,000 shares Expires 2031-02-17 F1 · derivative.exercise_date: These stock appreciation rights vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. F2 · derivative.underlying: These stock appreciation rights represent the right to receive a cash payment equal to the excess, if any, of (i) the fair market value of each underlying share of the Company's common stock, determined on the date of exercise minus (ii) the exercise price; provided, that in no event may the cash payment for each stock appreciation right exceed $1.03, which is the maximum price per share of $2.54, minus the base amount of $1.51, subject to adjustment in accordance with the terms of the award agreement. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 13:48 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseCommon Stock | 20,000 | $1.00 | $20,000.00 |
DisclosureSEC source: 0001179110-21-001783 · edgar.xml · nonDerivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,226 Read SEC document |
| November 25, 2020 Filed Nov 30, 2020 22:08 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseCommon Stock | 40,000 | $0.26 | $10,360.00 |
DisclosureSEC source: 0001179110-20-011468 · edgar.xml · nonDerivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,226 Read SEC document |
| July 09, 2020 Filed Jul 10, 2020 21:41 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Appreciation Right · Derivative | 1,273,800 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001179110-20-008208 · edgar.xml · derivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,273,800 Underlying: Common Stock · 1,273,800 shares Expires 2030-07-09 F1 · derivative.exercise_date: These stock appreciation rights vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| May 19, 2020 Filed May 20, 2020 13:07 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseCommon Stock | 26,800 | $0.37 | $9,857.04 |
DisclosureSEC source: 0001179110-20-006357 · edgar.xml · nonDerivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,226 Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 14:07 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 200,000 | $0.00 Strike: $0.31 | $0.00 |
DisclosureSEC source: 0001179110-19-013139 · edgar.xml · derivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2029-12-20 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 12:51 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseWarrant (right to purchase) · Derivative | 149,000 | Not disclosed Strike: $0.20 | Not disclosed |
DisclosureSEC source: 0001179110-19-012057 · edgar.xml · derivative · entry 2 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,000 Underlying: Common Stock · 149,000 shares Expires 2024-11-25 F1 · price: The common stock and warrants were acquired in a public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant. The public offering price for each unit was $0.20. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 12:51 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseCommon Stock | 149,000 | $0.20 | $29,800.00 |
DisclosureSEC source: 0001179110-19-012057 · edgar.xml · nonDerivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,426 F1 · price: The common stock and warrants were acquired in a public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant. The public offering price for each unit was $0.20. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 21:24 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 400,000 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001179110-18-010008 · edgar.xml · derivative · entry 1 Fruchtman Steven M · CIK 0001631251 · President, Chief Medical Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2028-07-26 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:50 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 43,627 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001179110-18-000602 · edgar.xml · derivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,627 Underlying: Common Stock · 43,627 shares Expires 2028-01-03 F1 · derivative.exercise_date: These options vest over three years in 36 equal monthly installments. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 18:30 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 26,401 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001179110-17-001041 · edgar.xml · derivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,401 Underlying: Common Stock · 26,401 shares Expires 2027-01-17 F1 · derivative.exercise_date: These options vest over three years in 36 equal monthly installments. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 21:42 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 7,599 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001179110-16-033202 · edgar.xml · derivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,599 Underlying: Common Stock · 7,599 shares Expires 2026-12-15 F1 · derivative.exercise_date: These options vest over three years in 36 equal monthly installments. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.